Skip to content
OpenCapital
Get started

Texas Instruments TXN Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp

Segments

By geography

See full
Europe, Middle East and Africa20%0.0%
Rest of Asia11%0.0%
Rest of world2%0.0%

Other financials

Income statement

See full
Revenue$5.5B+22.8%
Gross profit$3.4B+30.2%
Operating income$2.3B+47.8%
Net income$2.0B+52.9%
EPS (diluted)$2.14+51.8%

Balance sheet

See full
Cash & equivalents$3.7B+20.2%
Total debt$14.1B+0.1%
Total equity$18.0B+9.8%
Total assets$35.9B+2.7%

Cash flow

See full
Operating cash flow$2.7B+45.3%
CapEx$514.0M-60.6%
Free cash flow$2.2B+294%

Valuation

See full
Market cap$255.17B+48.3%
Enterprise value$265.56B+45.1%
P/E42.2×+8.0×
P/S13.1×+2.8×

Profitability

See full
Gross margin58.3%+0.3pp
Operating margin37.3%+2.4pp
Net margin31.1%+0.9pp
FCF margin27.5%+18.5pp

Returns & leverage

See full
Return on equity35.2%+5.2pp
Debt / equity0.8×-0.1×
Current ratio4.9×-1.0×